我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

丹参酮胶囊对糖尿病肾病患者成纤维细胞生长因子23-Klotho轴及血管钙化的影响(PDF)

《云南中医学院学报》[ISSN:1000-2723/CN:53-1048/R]

期数:
2016年02期
页码:
11-14
栏目:
实验研究
出版日期:
2016-04-10

文章信息/Info

Title:
Effect of Tanshinone Capsule on the Axis of Fibroblast Growth Factor 23-Klothoand Vascular Calcification in Patients with Diabetic Nephropathy
作者:
苏保林1陈刚毅1李敬2
1. 广州中医药大学第一附属医院,广东 广州 510405;2. 华南师范大学医院,广东 广州 510631
Author(s):
SU Baolin1 CHEN Gangyi1 LI Jing2
1. The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405, China;2. The Affiliated Hospital of South China Normal University, Guangzhou 510631, China
关键词:
丹参酮胶囊 糖尿病肾病 成纤维细胞生长因子23 Klotho 血管钙化
Keywords:
Tanshinone capsule diabetic nephropathy fibroblast growth factor 23 Klotho vascular calcification
分类号:
R285.6
DOI:
10.19288/j.cnki.issn.1000-2723.2016.02.004
文献标识码:
A
摘要:
目的通过观察糖尿病肾病(diabetic nephropathy,DN)患者成纤维细胞生长因子23(FGF23)、Klotho蛋白与颈动脉内膜中层厚度(CIMT)的相关性,初步探讨丹参酮胶囊对血管钙化的影响。方法选取DN-Ⅳ期患者71例,随机分为治疗组36例,对照组35例,均予基础治疗,治疗组加用丹参酮胶囊,治疗3个月后比较2组血肌酐(Scr)、钙(Ca)、磷(P)、血清白蛋白(Alb)、总胆固醇(CHOL)、甘油三酯(TG)、全段甲状旁腺激素(iPTH),血清FGF23、Klotho蛋白、TGF-β1、NF-κB、24h尿蛋白定量及C-IMT,选取同时期我院体检中心的健康志愿者35例作为健康对照组。结果治疗组明显降低患者CHOL、TG、血清TGF-β1、NF-κB、FGF23及尿蛋白总量,升高Klotho蛋白水平,抑制CIMT增厚,差异有统计学意义(P<0.05)。Spearman相关系数显示CIMT与尿蛋白定量、FGF-23水平呈正相关,与Klotho蛋白呈负相关(P<0.05)。结论丹参酮通过调控FGF23-Klotho轴改善CIMT,抑制血管钙化,或许与TGF-β1/NF-κB通路存在某种联系。
Abstract:
Objective To observe the correlation of fibroblast growth factor 23(FGF23), Klotho protein and carotid artery intima media thickness(CIMT) in diabetic nephropathy(DN) patients, and discuss the effect of Tanshinone capsule on vascular calcification. Methods A total of 71 cases of patients with DN stage IV, were randomly divided into treatment group(36 cases), control group(35 cases). All patients were treated with basic treatment, and the treatment group was added with Tanshinone capsule, after 3 months, serum creatinine(Scr), calcium(Ca), phosphorus(P), serum albumin(Alb), total cholesterol(CHOL), triglyceride(TG), intact parathyroid hormone(iPTH), serum FGF23, Klotho protein, TGF-β1, NF-κB, 24 hour urinary protein quantitative and CIMT were compared between the two groups, and selected 35 healthy volunteers as healthy control group. Results The treatment group had lower levels of CHOL、TG、serum TGF-β1、NF-κB、FGF23 and urinary protein quantitative, higher levels of Klotho protein, can inhibit CIMT thickening, the difference was statistically significant(P<0.05). Spearman correlation coefficient showed that CIMT was positively correlated with urinary protein quantitative and FGF23 levels(P<0.05), negatively correlated with Klotho protein(P<0.05). Conclusion Tanshinone capsule can reduce CIMT and inhibit vascular calcification by regulating the FGF23-Klotho axis, may be associated with TGF-β1/NF-κB pathway.

参考文献/References

[1] Reutens AT,Atkins RC. Epidemiology of diabetic nephropathy[J]. Contribution to Nephrology,2011,170(170):1-7.
[2] London GM. Cardiovascular Calcifications in Uremic Patients:Clinical Impact on Cardiovascular Function[J]. J Am Soc Nephrol,2003,14(9 suppl 4):S305-S309.
[3] Mogensen CE,Schmitz O. The diabetic kidney:from hyperfiltration and microalbum inuria to end-stage renal failure[J]. Medical Clinics of North America,1988,72(6):1465-1492.
[4] Mancia G,De Backer G,Dominiczak A,et al. 2007 guidelines for the management of arterial hypertension:the task force for the management of arterial hypertension of the European Society of hypertension(ESH)and of the European Society of Cardiology(ESC)[J]. Eur Heart J,2007,28(12):1462-1536.
[5] London GM,Guerin AP,Marehai SJ,et al. Arterial media calcification in end-stage renal disease:impact on all-cause and cardiovascular mortality[J]. Nephrol Dial Transplant,2003,18(9):1731-1740.
[6] Lorenz MW,Markus HS,Bots ML,et al. Prediction of clinical cardiovascular events with carotid intima-media thickness:a systematic review and meta-analysis[J]. Circulation. 2007,115(4):459-467.
[7] Shroff RC,Shanahan CM. The vascular biology of calcification[J]. Semin Dialysis,2007,20(2):103-109.
[8] Cozzolino M,Mazzaferro S,Pugliese F,et al. Vascular calcification and uremia:what do we[J]. American Joumal of Nephrology,2008,28(2):339-346.
[9] 马春园,郝丽荣. FGF23-Klotho轴在慢性肾脏病骨矿物质代谢紊乱中的作用[J]. 医学综述,2015,21(7):1169-1172.
[10] Urakawa I,Yamazaki Y,Shimada T,et al. Klotho converts canonical FGF receptor into a specific receptor for FGF23[J]. Nature,2006,444(7120):770-774.
[11] Srivaths PR,Goldstein SL,Silverstein DM,et al. Elevated FGF23 and phosphorus are associated with coronary calcification in hemodialysis patients[J]. Pediatr Nephrol,2011,26(6):945-951.
[12] Gutierrez O M,Januzzi J L,Isakova T,et al. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease[J]. Circulation,2009,119(19):2545-2552.
[13] 刘慧,开金龙. 丹参的现代研究进展[J]. 甘肃中医,2010,23(2):70-72.
[14] 李玉萍,顾兵,刘建涛,等. 丹参酮ⅡA的研究进展[J]. 时珍国医国药,2010,21(7):1770-1772.
[15] 陈刚毅,汤水福,苏保林,等. 丹参酮ⅡA对糖尿病肾病大鼠肾组织TGF-β1/NF-κB p65表达的影响[J]. 广州中医药大学学报,2015,32(5):891-895.

备注/Memo

备注/Memo:
* 基金项目: 广东省肾病重点专科资助 收稿日期: 2016 - 01 - 10 作者简介: 苏保林(1980-),男,河北沧州人,主治中医师,主要从事慢性肾脏病的临床和研究工作。E-mail:guangzhouyzh@126.com
更新日期/Last Update: 2016-03-20